scPharmaceuticals Inc (SCPH):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:scPharmaceuticals Inc (SCPH) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C8277
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:37
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ScPharmaceuticals Inc (scPharmaceuticals) is a clinical-stage pharmaceutical company. The company’s pipeline products include subcutaneous formulations of furosemide, ceftriaxone and carbapenem. Its furosemide formulation is a loop diuretic widely used in prescription pharmaceuticals for the management of edema in patients with decompensated heart failure due to the highly variable and overall reduction in the bioavailability of oral formulations. scPharmaceuticals’ Ceftriaxone is an antibiotic used intravenously for the treatment of infections caused by gram-positive and gram-negative organisms. The company’s carbapenems are antibotics used intravenously for the treatment of infections caused by gram-negative organisms. It also provides clinical trial services. scPharmaceuticals is headquartered in Burlington, Massachusetts, the US.

scPharmaceuticals Inc (SCPH) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
scPharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
scPharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
scPharma Raises USD45.6 Million in Series B Financing 11
scPharma Raises USD4 Million in Venture Financing 13
scPharma Raises USD8.18 Million in Venture Financing 14
scPharma Raises USD3.6 Million in Venture Financing 15
scPharma Raises USD3.6 Million in Venture Financing 16
scPharma Raises US$16 Million In Series A Financing 17
scPharma Raises USD9 Million in Venture Financing 18
Partnerships 19
Sensile Medical Enters Into Co-Development With scPharma 19
scPharma Enters Into Co-Development Agreement With Sensile Medical For Novel Heart Failure Treatment 20
Licensing Agreements 21
scPharmaceuticals Enters into License Agreement with Sensile Medical 21
Equity Offering 22
scPharma Raises USD102 Million in IPO 22
Acquisition 24
Sun Pharma Acquires 14.58% Stake in scPharma for USD13 Million 24
scPharmaceuticals Inc – Key Competitors 25
scPharmaceuticals Inc – Key Employees 26
scPharmaceuticals Inc – Locations And Subsidiaries 27
Head Office 27
Recent Developments 28
Financial Announcements 28
Aug 14, 2018: scPharmaceuticals announces second quarter 2018 financial results 28
May 07, 2018: scPharmaceuticals Announces First Quarter 2018 Financial Results 29
Mar 20, 2018: scPharmaceuticals Inc. Reports Fourth Quarter 2017 Financial Results 31
Corporate Communications 32
Jun 28, 2018: scPharmaceuticals Names Frederick Hudson As Board Director 32
Apr 26, 2017: John Tucker Appointed as Chief Executive Officer of scPharmaceuticals 33
Product Approvals 34
Nov 06, 2017: First US FDA Submission of Wearable Drug-Device Combination Product Based on Sensile Medicals SensePatch Drug Delivery Technology 34
Nov 02, 2017: scPharmaceuticals Announces FDA Acceptance of NDA for Furoscix (subcutaneous furosemide) 35
Clinical Trials 36
Jan 24, 2017: scPharmaceuticals Announces Start of SUBQ-HF NHLBI Study with Its Subcutaneous Furosemide Product 36
Appendix 37
Methodology 37
About GlobalData 37
Contact Us 37
Disclaimer 37

List of Tables
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Key Facts 2
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
scPharmaceuticals Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
scPharmaceuticals Inc, Deals By Therapy Area, 2012 to YTD 2018 8
scPharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
scPharma Raises USD45.6 Million in Series B Financing 11
scPharma Raises USD4 Million in Venture Financing 13
scPharma Raises USD8.18 Million in Venture Financing 14
scPharma Raises USD3.6 Million in Venture Financing 15
scPharma Raises USD3.6 Million in Venture Financing 16
scPharma Raises US$16 Million In Series A Financing 17
scPharma Raises USD9 Million in Venture Financing 18
Sensile Medical Enters Into Co-Development With scPharma 19
scPharma Enters Into Co-Development Agreement With Sensile Medical For Novel Heart Failure Treatment 20
scPharmaceuticals Enters into License Agreement with Sensile Medical 21
scPharma Raises USD102 Million in IPO 22
Sun Pharma Acquires 14.58% Stake in scPharma for USD13 Million 24
scPharmaceuticals Inc, Key Competitors 25
scPharmaceuticals Inc, Key Employees 26

List of Figures
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
scPharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
scPharmaceuticals Inc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[scPharmaceuticals Inc (SCPH):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Galectin Therapeutics Inc.:企業のM&A・事業提携・投資動向
    Galectin Therapeutics Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Galectin Therapeutics Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acqui …
  • Newfield Exploration Co (NFX):石油・ガス:M&Aディール及び事業提携情報
    Summary Newfield Exploration Co (Newfield) is an independent upstream company. The company focuses on onshore large scale, liquids-rich resource plays. Its domestic assets are in the Anadarko and Arkoma basins of Oklahoma, the Williston Basin of North Dakota and the Uinta Basin of Utah. The company …
  • Nuclear Power Corporation of India Ltd:企業の戦略的SWOT分析
    Nuclear Power Corporation of India Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Marsulex Environmental Technologies Corp:企業の戦略的SWOT分析
    Marsulex Environmental Technologies Corp - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and …
  • Global Clean Energy Holdings Inc:企業の戦略的SWOT分析
    Global Clean Energy Holdings Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pr …
  • Building Energy SpA:石油・ガス:M&Aディール及び事業提携情報
    Summary Building Energy SpA (Building Energy) is a renewable energy company that operates and develops renewable energy projects such as biomass, hydro, wind and solar projects. The company provides operation and maintenance services such as real time performance monitoring, performance guarantee, p …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Mitsui Oil Exploration Co Ltd:企業の戦略的SWOT分析
    Mitsui Oil Exploration Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produ …
  • VolitionRX Ltd (VNRX):企業の財務・戦略的SWOT分析
    Summary VolitionRX Ltd (VolitionRX) is a medical equipment provider that develops diagnostics tests for cancer and other conditions. The company develops Nucleosomics, a platform technology used for measurement and identification of nucleosomes in the blood. It develops tools for the diagnosis of va …
  • AmWINS Group Inc:企業のM&A・事業提携・投資動向
    AmWINS Group Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's AmWINS Group Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), dives …
  • Ameresco Inc (AMRC):電力:M&Aディール及び事業提携情報
    Summary Ameresco, Inc. (Ameresco) provides comprehensive energy services, including energy efficiency, infrastructure upgrades, asset sustainability and renewable energy solutions. It also offers energy infrastructure facility upgrade; and development, construction and operation of renewable energy …
  • Jadason Enterprises Limited (J03):企業の財務・戦略的SWOT分析
    Jadason Enterprises Limited (J03) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • HeartWare International Inc:医療機器:M&Aディール及び事業提携情報
    Summary HeartWare International Inc (HeartWare), subsidiary of Medtronic Plc, is a medical device company that develops and manufactures ventricular assist devices and implantable heart pumps for the treatment of advanced heart failure. The company provides HeartWare Ventricular Assist System that c …
  • Just Energy Group Inc. (JE):企業の財務・戦略的SWOT分析
    Just Energy Group Inc. (JE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • Landstar System, Inc.:企業の戦略・SWOT・財務分析
    Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report Summary Landstar System, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Xped Ltd (XPE):企業の財務・戦略的SWOT分析
    Xped Ltd (XPE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Crown Bioscience Inc-医療機器分野:企業M&A・提携分析
    Summary Crown Bioscience Inc (Crown Bioscience) is a pharmaceutical company that provides drug discovery and development services. The company offers in vivo and in vitro research reagents. It offers preclinical contract research services in areas of oncology and metabolic disease. Crown Bioscience’ …
  • China Huaneng Group:企業の発電所・SWOT分析2018
    China Huaneng Group - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employees …
  • TransDigm Group Incorporated:企業のM&A・事業提携・投資動向
    TransDigm Group Incorporated - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's TransDigm Group Incorporated Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Cardinal Ethanol LLC (CRDE):企業の戦略的SWOT分析
    Cardinal Ethanol LLC (CRDE) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆